Dominant Host Range Selection of Vaccinia Recombinants by Rescue of an Essential Gene  by Holzer, Georg W. et al.
Dominant Host Range Selection of Vaccinia Recombinants by Rescue of an Essential Gene
Georg W. Holzer, Werner Gritschenberger, Josef A. Mayrhofer, Verena Wieser,
Friedrich Dorner, and Falko G. Falkner1
Hyland-Immuno, Biomedical Research Center, Uferstrasse 15, A-2304 Orth/Donau, Austria
Received April 30, 1998; returned to author for revision May 27, 1998; accepted June 25, 1998
We report the rescue of a defective vaccinia virus, forming the basis for a stringent selection protocol to generate
replicating recombinant virus without the need for marker cassettes and selection agents. Plaques of recombinant virus
could be isolated solely by their ability to grow in wild-type cells normally supporting the growth of vaccinia virus. All
growth-competent clones analyzed contained the gene of interest in the intended genomic locus and displayed foreign gene
expression to the same levels as was seen with classical recombinants obtained by insertion into the vaccinia virus thymidine
kinase locus. The system is based on a defective vaccinia virus, expressing exclusively early genes, termed eVAC-1, and an
insertion plasmid vector providing the essential function, the uracil DNA glycosylase gene. In addition, the defective virus is
free of selection and color marker genes, thus also representing a basic vector for the generation of defective recombinants.
© 1998 Academic Press
INTRODUCTION
Vaccinia virus (VV) is a large DNA virus that is widely
in use as a cytoplasmic expression vector. The double-
stranded genome is ;190 kbp in size and can accom-
modate up to 50 kb of foreign DNA in several different
genomic loci (for reviews, see Moss, 1996a; Paoletti,
1996; Carroll and Moss, 1997). Recombinant VVs are
commonly generated by homologous recombination be-
tween a plasmid vector and a nonessential region of the
viral genome (Panicali and Paoletti, 1982). Several selec-
tion procedures have been described to isolate recom-
binant virus, including thymidine kinase (tk)-negative se-
lection (Mackett et al., 1982), chemical selection by
marker genes (Franke et al., 1985; Falkner and Moss,
1988; Boyle and Coupoar, 1988; Isaacs et al., 1990; Zhou
et al., 1991), color screening (Chakrabarti et al., 1985;
Carroll and Moss, 1995), and marker rescue. Previously
described marker rescue protocols take advantage of
mutant parental viruses that are depleted in a function
that is dispensable for replication of the virus but alters
its phenotype. Restoration of the depleted function by an
integration vector allows identification of the recombi-
nant clones. Selection criteria are plaque size (Rodriguez
and Esteban, 1989), plaque formation (Blasco and Moss,
1995), and host range (Perkus et al., 1989). In the latter
system, the host range gene K1L was deleted from the
parental virus, impairing viral growth in certain human
cell lines. Rescued recombinants were scored by their
restored ability to grow in MRC-5 cells.
Recently, we constructed a VV with a deletion in the
essential open reading frame (ORF) D4R, encoding the
enzyme uracil DNA glycosylase (UDG) and thus obtain-
ing a virus that does not replicate in natural hosts (Holzer
and Falkner, 1997). Because the enzyme UDG is required
for replication (Upton et al., 1993; Stuart et al., 1993), the
viral life cycle is blocked in wild-type (wt) cells in an early
stage of transcription (Millns et al., 1994). The defective
virus is therefore dependent on an engineered comple-
menting cell line. This prompted us to attempt marker
rescue with the UDG gene to generate growth-compe-
tent recombinants expressing foreign genes in the D4
locus. We constructed an improved defective virus de-
signed as a parental vector for a broad range of appli-
cations, including D4R marker rescue. Based on this
vector, we performed rescue with an integration plasmid
providing the UDG gene. To evaluate the efficiency of the
system, the hepatitis B virus (HBV) preS1 large surface
protein was expressed as a model antigen. Growth-
competent clones were obtained readily and expressed
the foreign gene at a frequency of 100%.
RESULTS
Construction of the D4R free parental virus eVAC-1
Because the ORFs D3R, D4R, and D5R are essential
for viral growth (for a review, see Johnson et al., 1993)
and are arranged in a dense, partly overlapping manner
(Fig. 1), in the first-generation defective virus vD4-ZG
(Holzer and Falkner, 1997) only the central part of the
D4R ORF was deleted with a total of 0.3 kb of D4R
sequence remaining in the genome. In preliminary
marker rescue experiments with this virus, only 70% of
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the growth-competent isolates contained the gene of
interest (G. W. Holzer, unpublished observations), sug-
gesting that recombination events within the residual
D4R sequences allowed undesired repair of the deletion
without cointegration of the foreign gene. Previous stud-
ies have addressed the need for a low homology be-
tween the marker gene and the parental virus for efficient
selection (Blasco and Moss, 1995). Therefore, we entirely
removed the D4R sequences as a prerequisite for strin-
gent marker rescue. As a second goal, the novel vector
should not contain the marker genes lacZ and gpt to
allow their application in subsequent classic selection
protocols.
For this purpose, the plasmid pDW was constructed,
containing 59 sequences (D3R) and 39 sequences (D5R)
that immediately flank the D4R gene, within which was
placed a double-marker cassette. The cassette con-
sisted of a gpt/lacZ expression unit framed by a noncod-
ing tandem repeat of 0.45 kb at each side, thus rendering
the marker genes unstable in the viral context in the
absence of selection pressure (Scheiflinger et al., 1998).
Homologous recombination of the pDW plasmid into wt
virus and selection for recombinants were done in the
UDG-complementing cell line RK-D4R-44.20. After sev-
eral rounds of blue plaque screening in the presence of
mycophenolic acid, the isolates were assayed for the
inability to grow in RK13 wt cells and purified for an
additional two rounds of screening for white plaques in
the absence of the selective agent. The resulting virus,
designated eVAC-1, was free of marker genes and con-
tained a single copy of the repeated sequence at the site
of the deleted D4R gene. Maps of this vector and the wt
virus are depicted in Figure 1.
Southern blotting was done to confirm the structure of
the genomic locus and to demonstrate that the defective
virus eVAC-1 shares, in contrast to the first-generation
construct, no common sequences with the D4R ORF (Fig.
2). Hybridization with a D4R-specific probe (Fig. 2A) gave
signals with wt and vD4-ZG (lanes 2 and 3) but not with
eVAC-1 (lane 4). A second probe, homologous to D4R
flanking sequences, hybridized to the expected 5.8-kb
band in the eVAC-1 digest (Fig. 2B, lane 4), whereas no
traces of parental structures could be detected.
The replication defective vector eVAC-1 exhibits
undiminished growth in the complementing cell line
Propagation kinetics of the vector are a critical param-
eter for an efficient expression system. The growth prop-
erties of eVAC-1 were assessed as previously described
for the mutant vD4-ZG (Holzer and Falkner, 1997). In the
complementing cell line RK-D4R-44.20, growth was ini-
tially somewhat delayed. However, the final titers ob-
tained after 3–4 days were comparable to those of the wt
Western Reserve (WR) strain (Fig. 3), suggesting that the
complete deletion of the D4R gene in eVAC-1 did not
negatively affect any adjacent function. With the initial
dose of infection in this experiment (2 3 104 pfu), eVAC-1
could not be recovered from RK13 wt cells later than 8 h
p.i., which is consistent with its defective character (data
not shown). The virus is also intended to be used as a
basic defective mutant for foreign gene insertion into the
D4R locus and into common nonessential genomic sites.
The lack of any markers should allow for the application
of classic selection protocols to generate further defec-
tive recombinants.
Dominant host range selection for the generation of
vaccinia recombinants
We next attempted rescue of the essential UDG
gene for the generation of replicating recombinants.
FIG. 2. Genomic viral DNAs of VV wt (lane 2), vD4-ZG (lane 3), and
eVAC-1 (lane 4) were digested with EcoRI and analyzed by Southern
blotting. When a D4R-specific probe was used (A), signals were ob-
tained only with wt or vD4-ZG. In the second blot (B), an overlapping
probe was used as depicted in Figure 1.
FIG. 1. Genomic organization of the D4R gene and adjacent ORFs.
The essential gene D4R (gray) is intact in the wt virus, where in eVAC-1
it is entirely replaced by a short segment of foreign DNA [a 0.45-kb
noncoding phiX DNA fragment (n)]. Orientation of the ORFs are indi-
cated (arrows). EcoRI restriction sites and the respective fragment
sizes (given in kb) are shown. (Bold lines) Probes used for Southern
blotting.
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Basically, the integration plasmid for this purpose
should contain the D4R gene, preferably under control
of its natural promoter, and a multiple cloning site for
the insertion of foreign DNA, both flanked by genomic
sequences driving homologous recombination. It was
intended to achieve integration of foreign DNA into the
D4-locus, thereby placing the UDG gene back into its
natural context. Therefore, the plasmid pER was con-
structed (Fig. 4A). Genomic VV sequences were
cloned, composed of the complete UDG gene and
;0.5 kb of adjacent regions at each side. A multiple
cloning site for the integration of foreign gene cas-
settes was inserted immediately downstream of the
D4R gene. To demonstrate foreign gene transfer with
this vector, we cloned a gene cassette, consisting of a
strong vaccinia synthetic early-late promoter
(Chakrabarti et al., 1997) and the ORF of the HBV large
antigen preS1, into the cloning sites of pER (Fig. 4B).
Homologous recombination of the plasmid pER-preS1
into the virus eVAC-1 was performed by infecting differ-
ent cell lines, such as monkey CV1, rabbit RK13, or
human 143B, at an m.o.i. of 0.1 pfu/cell and subsequent
transfection of the cells with plasmid DNA. Recombi-
nants were obtained in all three cell lines, although at
different efficiencies, whereas even after an unusually
long incubation time of 4 days, plaques were not ob-
served in the control infections. The procedure was
therefore termed dominant host range selection. Uptake
of the D4R ORF resulted in rescue of the normal WR wt
phenotype, whereas the parental vector eVAC-1 displays
the narrowest possible host range, thus allowing selec-
tion of recombinants in all the host cell lines tested.
Routinely, between 2 (in CV-1 or 143B cells) and 20
plaques (in RK13 cells)/105 pfu of defective input virus
were observed. To demonstrate the efficiency of the
procedure, plaques were visualized by crystal violet
staining of the infected/transfected cells (Fig. 5). Al-
though the monolayers of RK13 cells and CV1 cells did
not exhibit morphological changes on eVAC-1 infection
at 0.1 pfu/cell, the 143B cells were considerably dam-
aged, which somewhat hampered the detection of re-
combinant virus (not shown). Due to the stringent selec-
tive conditions present at the time of recombination, a
simplified plaque purification protocol could be devel-
oped (see Materials and Methods). We applied a proce-
dure for isolating recombinants that was substantially
reduced in time and labor compared with standard meth-
FIG. 3. Growth kinetics of the defective virus eVAC-1. Complementing
RK-D4R-44.20 cells (5 3 106 cells) were infected with 2 3 104 pfu of the
virus eVAC-1. The cells were harvested at the indicated times, crude
stocks were prepared, and the total amount of virus was determined
using RK-D4R-44.20 cells for the titration assay. As a control, wt virus
(WR-wt/RK13) was propagated and titrated in RK wt cells. Average
values of two independent experiments are shown.
FIG. 4. Maps of the plasmids pER and pER-preS1. The construct pER
(A) contains the intact D4R gene (gray box) and additional VV-se-
quences belonging to the adjacent ORFs D3R and D5R. The D4 pro-
moter (arrow, upstream of D4R) is located within the D3 ORF; cloning
sites as indicated are present between the D4 gene and the D5-
promoter. The plasmid pER-preS1 (B) contains the HBV large antigen
gene cassette (black) in the intergenic region between D4R and D5R.
The direction of transcription is from left to right for all ORFs shown.
EcoRI sites (E) relevant for Southern blot analyses are indicated.
FIG. 5. Plaque formation by rescued virus after infection with the
defective virus and transfection of the essential gene. The cell lines
CV-1 (A) and RK13 (B) were infected with the defective VV eVAC-1 at an
m.o.i. of 0.1 pfu/cell. Cells were transfected with the plasmid pER-preS1
or mock transfected; crystal violet staining was done 4 days later.
162 HOLZER ET AL.
ods. As early as 3 h p.i./post-transfection in CV1 cells, the
medium was replaced by a Dulbecco’s modified Eagle’s
medium (DMEM)–1% low melting point agarose overlay,
and plaques were directly picked after 3 days without
preparation of a recombination crude stock and plating
of serial dilutions. After a second round of plaque puri-
fication, isolates were amplified and virion preparations
were made.
One hundred percent of the growth competent virus
isolates contain the gene of interest
To monitor the efficiency of the selection procedure,
we characterized the genomic structure of 10 isolates by
Southern blotting. The viruses, obtained by recombina-
tion of pER-preS1 DNA and eVAC-1 as described above,
were termed vRES-preS1. All of the recombinants (Fig.
6A, lanes 4–13) had the predicted structure, containing
the HBV DNA as revealed by an HBV-specific probe. As
expected, two HBV bands, a strong 1.1-kb fragment and a
weak 0.4-kb fragment, were observed in EcoRI digests of
the isolates. Hybridization with a probe specific for D4R
overlapping sequences (Fig. 6B) demonstrated that the
isolates were free of the parental vector eVAC-1 and
contained the essential D4R ORF, represented by a
0.65-kb band as well as the 2.2-kb upstream fragment
(lanes 4–13). Thus, initial plaque picking and one further
round of purification are sufficient to obtain pure recom-
binant virus.
The isolates displayed wt titers ranging between 5 3
107 and 5 3 108/10-cm (5 3 106 cells) dish, confirming
that insertion of foreign DNA into the intergenic region
between the two essential genes D4R and D5R does not
negatively affect viral growth.
We were also interested in whether the genomic inte-
gration locus would allow for high level expression of the
transgene. Whole-cell lysates of infected CV-1 cells were
therefore analyzed by Western blotting using an HBV-
specific antibody (Fig. 7). Expression of the HBV large
antigen was comparable to that observed with the virus
vselP-gpt-L2/preS1dMyr, in which an identical preS1
gene cassette is integrated in the tk locus. Similar
amounts of the preS1 glycosylation forms gp42 and p39
were found in vRES-preS1 infects (lanes 2–7) and in the
positive control vselP-gpt-L2/preS1dMyr (lane 9), con-
firming the usefulness of the D4R/D5R intergenic region
as an integration site for foreign genes.
DISCUSSION
Marker rescue, the principle of the selection system
presented here, is well established. In a previous report
(Perkus et al., 1989), a host range selection system was
described that is based on a parental virus lacking the
human host range gene K1L, thus being growth re-
FIG. 6. Southern blot analysis of rescued viral recombinants. EcoRI
digests of viral DNA from vaccinia wt (lanes 2), from the defective
mutant eVAC-1 (lanes 3), and from 10 rescued vRES-preS1 recombi-
nants (lanes 4–13) were separated by inversed field electrophoresis
and blotted onto nylon membranes. Hybridization was performed either
with a 1.5-kb fragment containing the entire HVB preS1 gene cassette
(A) or with a probe homologous to sequences overlapping with the D4R
gene (B), as described in Figure 2B.
FIG. 7. Expression of the HBV large antigen in cells infected with the
rescued viruses. CV-1 cells were infected at an m.o.i. of 0.1 pfu/cell, and
whole-cell lysates were prepared 3 days p.i., separated on a 12%
SDS–polyacrylamide gel, and analyzed by Western blotting. Infections
are shown of six isolates of the recombinant vRES-preS1 (lanes 2–7),
mock infected CV-1 cells (lane 8), and vselP-gpt-L2/preS1dMyr infected
CV-1 cells (lane 9). By using a monoclonal anti-preS1-antibody, two HBV
preS1 glycosylation forms are detected (arrows).
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stricted in human cell lines. The fundamental difference
between the present approach and previous studies is
the fact that the parental virus described here is replica-
tion negative in any natural host cells and thus allows
selection in all cell types supporting growth of VV. Se-
lection pressure for the recombinant is maintained
throughout purification and propagation of an isolate,
independent of the cell culture system and without the
need for expensive selection drugs. Importantly, the pa-
rental virus is unable to outgrow the replication compe-
tent recombinants, and we speculate that this system
might also allow for the isolation of vaccinia recombi-
nants that are otherwise difficult to grow. In the course of
experiments with vRES-preS1, we also tried to propagate
isolates without any plaque purification, expecting that
residual parental virus would disappear due to its defec-
tive phenotype. However, Southern blotting revealed low
amounts of eVAC-1 genomes in single-step amplified
crude stocks (data not shown), suggesting that the D41
recombinant acted as a helper virus to permit limited
replication of the D42 mutant. Previous studies using
different cell lines (Holzer and Falkner, 1997) demon-
strated that titers of the D42 mutant alone drop beyond
the detection limit within 4 days of infection in different
cell lines, excluding leakiness as an explanation for the
presence of eVAC-1 genomes in single-step stocks.
The maintained selection pressure is a unique at-
tribute of the dominant host range selection. Previ-
ously described dominant selection methods require
the application of drugs, which are usually withdrawn
after plaque purification of an isolate for expense
reasons. On the other hand, phenotype screening by
marker rescue of nonessential genes or by color mark-
ers does not provide selective conditions and there-
fore demands excessive purification of the isolates.
Theoretically, permanent selection pressure could be
achieved with rescued conditional lethal mutants,
such as temperature-sensitive (ts) mutants, when the
appropriate culture conditions are chosen. The ts se-
lection protocols are not used as widely as dominant
markers, most probably because ts phenotypes are
commonly leaky and tend to revert at considerable
frequency (Condit et al., 1983; Ensinger, 1982).
Reversion of the parental defective virus to wt in the
complementing cell line was also an issue to be ad-
dressed with the defective mutants. Although replicat-
ing revertants of ts mutants arise by random repair of
the conditionally lethal point mutations, growth of D4
defective mutants might be restored by uptake of the
intact D4R ORF from the complementing cell line.
Although the first generation of defective mutants still
contained residual D4 sequences, allowing for homol-
ogous recombination with the nuclear host DNA, re-
version was observed at relatively low frequency. In 5
of 10 assayed defective stocks made with a first-
generation vector (Holzer et al., 1998, submitted) no
replicating virus was found per 106 defective particles.
The other stocks contained 1–6 replication competent
viruses/106. The revertants were identified by se-
quencing because an acquired D4R can be differenti-
ated from contaminations with wt virus by a silent
mutation present in the cell-derived D4 gene (A3T at
position 450). However, with the vector eVAC-1, re-
moval of the sequences responsible for homologous
recombination resulted in markedly reduced reversion
tendency. In reversion assays, we were unable to
detect growth-competent virus among 4 3 107 defec-
tive particles.
The early gene expressing defective virus eVAC-1 is
therefore suitable as a basic vector for two different
goals. First, it is suitable as an insertion vector for re-
combinant defective viruses. Most insertion plasmids
are appropriate for generating replication-negative re-
combinants in different genomic loci when eVAC-1 is
used as parental virus. Recombinants of this kind could
serve as safe tools for protein expression or as nonrep-
licating live vaccines. Second, the marker rescue ap-
proach with the insertion plasmid pER is well suited for
obtaining replication competent recombinants, espe-
cially when further insertions with marker gene cas-
settes into distinct loci are intended or when selection at
high stringency is required. Because serial dilutions and
plating of the recombination crude stock can be omitted,
the protocol also allows for the rapid detection of infre-
quent recombination events within 3 days.
Early VV genes like D4R are commonly transcribed
from within the core of the entering virus (Moss, 1996b),
theoretically excluding productive transfection of early
genes. Surprisingly, UDG was expressed from the exter-
nal plasmid template pER-preS1 in sufficient amounts to
allow for the dominant host range selection approach. As
reported previously, D4-defective mutants are arrested in
the early stage of transcription, lasting at least 8 h, due
to the block in viral replication. On the other hand, dis-
assembly of the viral cores has been proposed to be
driven by cellular factors or by one or more early viral
proteins (Pedley and Cooper, 1987) and should therefore
take place independently of this block. Increasing leak-
iness of the viral core along this process is therefore a
possible explanation for the accessibility of the viral RNA
polymerase to the plasmid DNA template.
Our data give no indication of attenuation of the D4
rescued recombinant isolates compared with the WR wt
in cell culture. The vector pER introduces foreign DNA
between the essential genes D4R and D5R, without af-
fecting the promoter region of D5R. The critical early
region of the D5R gene has been characterized previ-
ously (Lee-Chen et al., 1988), and the excellent growth
properties of the virus eVAC-1 confirmed that essential
promoter signals do not extend into the D4 coding re-
gion. The wt mRNA of the D4R gene is untypical for
vaccinia early transcripts, coterminating with D5R tran-
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scripts ;3 kbp downstream of the ORF D4R (Evans and
Traktman, 1987; Lee-Chen et al., 1988; Roseman and
Hruby, 1987). The function of this extended mRNA is not
yet clear. However, interruption of the transcript by inser-
tion of the HBV large antigen gene cassette, introducing
additional early transcription termination signals, caused
no detectable changes in viral growth or expression,
supporting the feasibility of the D4/D5 intergenic region
for foreign gene expression.
Taking advantage of the growth restriction of the vec-
tor eVAC-1 to a single engineered cell line, a simple and
efficient selection procedure was developed in which
selective pressure is maintained independently of the
cell line and without the need for additional drugs. Thus,
the general approach of dominant host range selection
provides a stringent and substantially time-saving method
for obtaining vaccinia recombinants, extends the possi-
bilities to construct poxviral recombinants with multiple
inserts, and will be applicable for the construction of
recombinants of related poxviruses.
MATERIALS AND METHODS
Cells and viruses
The rabbit kidney cell line RK13 (ATCC CCL 37), the
African green monkey cell line CV-1 (ATCC CCL 81),
and the WR strain of VV were obtained from the Amer-
ican Type Culture Collection. The cell line RK-D4R-
44.20 and the VV vD4-ZG have been described previ-
ously (Holzer and Falkner, 1997). Cells were grown in
DMEM containing 10% of fetal calf serum. Purified viral
stocks were prepared essentially as described previ-
ously (Joklik, 1962).
Construction of plasmids
pD4-vA. A 4.7-kb fragment containing an instable lacZ/
gpt marker cassette was prepared from the PstI- and
NotI-digested plasmid ptk-vA-CMenvb, a derivate of
pvA2 (Scheiflinger et al., 1998). Ligation into PstI- and
NotI-digested pD4Rf (Holzer and Falkner, 1997) gave the
plasmid pD4-vA.
pDW. Inverse polymerase chain reaction (PCR) was
performed to delete D4R sequences from the plasmid
pD4-vA using the primers oD4–8 (59-AAG CTT TAG TGA
AAT TTT AAC TTG TGT TC-39) and oD4–9 (59-CAT TAT
ATC AAA TTA GAT ACC TTT TTA TAC G-39). The recircu-
larized plasmid was cut with HindIII and treated with
Klenow polymerase, and the marker cassette was in-
serted as a 4.7-kb SmaI fragment from ptk-vA-CMenvb.
The resulting vector was termed pDW.
pER. A 0.6-kb fragment of the D4R ORF was obtained
by MunI/NotI digestion of the plasmid pCR-D4R and was
ligated with MunI/NotI cut p1T-D4. Both of these plas-
mids have been described previously (Holzer and
Falkner, 1997). The resulting plasmid, designated pT3–
2S, contains the complete D4R ORF and additional up-
stream flanking viral sequences. A 0.65-kb PCR frag-
ment, containing the downstream flanking sequences of
D4R, was amplified from VV WR DNA with the primers
oD4–4 (59-GGA TCC TAG TAC CTA CAA CCC GAA GAG-
39) and oD4–8. The fragment was subcloned into the
vector pCRII (InVitrogen) and excised by BamHI and
EcoRV digest. Ligation with BamHI- and StuI-digested
pT3–2S resulted in the integration plasmid pER.
pER-preS1. A gene cassette containing the strong syn-
thetic VV promoter selP and an ORF coding for a modi-
fied hepatitis B virus large antigen (preS1) was excised
as a 1.5-kb SalI/NotI fragment from the plasmid pse1P-
gpt-L2/preS1dMyr (Pfleiderer et al., 1995) and cloned into
XhoI and NotI cut pER.
Generation of the defective virus eVAC-1
Twenty micrograms of the plasmid pDW were trans-
fected into VV WR-infected RK-D4R-44.20 cells by cal-
cium phosphate precipitation (Graham and van der Eb,
1973) and further processed as described previously
(Scheiflinger et al., 1998).
Dominant host range selection procedure
CV1 cells were infected with eVAC-1 at an m.o.i. of 0.1
pfu/cell. After an adsorption period of 30 min, the cells
were transfected with 20 mg of pER-preS1 DNA by cal-
cium phosphate precipitation. Three hours later, the me-
dium was replaced by a 1% low gelling point agarose/
DMEM overlay. Plaques were picked after 3 days. Iso-
lates were plaque purified once and expanded for large-
scale preps.
Reversion assay of defective VV
To detect replication competent virus in defective virus
stocks, ten 175-cm2 cell culture flasks of confluent CV-1
cells were infected with a total of 4 3 107 pfu. Plaques of
replication competent virus were visualized by crystal
violet staining at 3 days p.i.
Southern blotting
Blotting was done according to standard protocols; a
0.66-kb fragment of the plasmid pCR-D4R served as the
D4R-specific probe. An overlapping probe containing the
D4R 59-flanking sequences and 0.2 kb of the D4R ORF
was amplified as a 0.8-kb PCR fragment from VV WR
DNA with the primers oD4–3 and 0D4–5 (Holzer and
Falkner, 1997). A preS1-specific probe was obtained as a
1.5-kb HindIII/NotI fragment of the plasmid pselP-gpt-L2/
preS1dMyr.
Western blotting
Whole-cell lysates were resolved on a 12% polyacryl-
amide gel, and blotting was performed essentially as
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described previously (Towbin et al., 1979). To detect HBV
preS1 antigen in Western blots, a monoclonal antibody
specific for the first 108 amino acids of the protein was
used (Pfleiderer et al., 1995).
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